These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New options for drug treatment of obesity in patients with Type 2 diabetes. Kennedy RL; Khoo EY Diabet Med; 2005 Sep; 22 Suppl 4():23-6. PubMed ID: 16109016 [No Abstract] [Full Text] [Related]
8. Current pharmacotherapeutic concepts for the treatment of obesity in adults. Idelevich E; Kirch W; Schindler C Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):75-90. PubMed ID: 19144669 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy for weight loss in patients with type 2 diabetes]. Toubro S Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907 [No Abstract] [Full Text] [Related]
10. Pharmacologic treatment for obesity. Options for today...and tomorrow. Lundquist LM; Sirimaturos M; Cannon E Adv Nurse Pract; 2006 Aug; 14(8):31-5, 64. PubMed ID: 16972485 [No Abstract] [Full Text] [Related]
11. Long-term medication use and weight loss maintenance: an observational study. Womble LG; Wadden TA; Berkowitz RI; Sarwer DB; Rothman RA Obes Res; 2001 Oct; 9(10):652-3. PubMed ID: 11595785 [No Abstract] [Full Text] [Related]
12. [Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review]. Madsbad S Ugeskr Laeger; 2011 Feb; 173(8):564-7. PubMed ID: 21333255 [TBL] [Abstract][Full Text] [Related]
13. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. Després JP; Golay A; Sjöström L; N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982 [TBL] [Abstract][Full Text] [Related]
14. [Association of obesity and depression]. Rihmer Z; Purebl G; Faludi G; Halmy L Neuropsychopharmacol Hung; 2008 Oct; 10(4):183-9. PubMed ID: 19213197 [TBL] [Abstract][Full Text] [Related]
15. The new role of pharmacotherapy for weight reduction in obesity. Fernstrom MH; Fernstrom JD Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacotherapy of obesity]. Svendsen OL Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112 [No Abstract] [Full Text] [Related]
17. [New drugs for the treatment of obesity]. Mustajoki P Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921 [No Abstract] [Full Text] [Related]
18. Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Gadde KM; Allison DB Circulation; 2006 Aug; 114(9):974-84. PubMed ID: 16940206 [No Abstract] [Full Text] [Related]
19. Effect of antiobesity medications in patients with type 2 diabetes mellitus. Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442 [TBL] [Abstract][Full Text] [Related]
20. [Weight reduction. Antiobesity drug treatment in type-2 diabetics]. Verspohl EJ Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127 [No Abstract] [Full Text] [Related] [Next] [New Search]